One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
2022: a banner year for systemic lupus erythematosus?
doi : 10.1016/S2665-9913(22)00163-1
Volume 4, Issue 7, July 2022, Page e451
The long and winding road of revision hip replacement
doi : 10.1016/S2665-9913(22)00158-8
Volume 4, Issue 7, July 2022, Pages e452-e453
Botulinum toxin A: a short-term treatment option for base-of-thumb osteoarthritis?
Anna Døssing a, Henning Bliddal a
Racial and ethnic differences in COVID-19 outcomes: a call to action
doi : 10.1016/S2665-9913(22)00135-7
Volume 4, Issue 7, July 2022, Pages e455-e457
Plasma protein correlates of skin severity in systemic sclerosis
Shervin Assassi a
Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases
doi : 10.1016/S2665-9913(22)00099-6
Volume 4, Issue 7, July 2022, Pages e458-e461
Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis
doi : 10.1016/S2665-9913(22)00100-X
Volume 4, Issue 7, July 2022, Pages e462-e464
Global access to biological disease-modifying drugs
doi : 10.1016/S2665-9913(22)00160-6
Volume 4, Issue 7, July 2022, Page e465
Christiaan Scott: beacon for paediatric rheumatology on the African continent
doi : 10.1016/S2665-9913(22)00165-5
Volume 4, Issue 7, July 2022, Page e467
How long do revised and multiply revised hip replacements last? A retrospective observational study of the National Joint Registry
doi : 10.1016/S2665-9913(22)00097-2
Volume 4, Issue 7, July 2022, Pages e468-e479
Intra-articular botulinum toxin A injection for painful base-of-thumb osteoarthritis: a double-blind, randomised, controlled, phase 3 trial (RHIBOT)
Prof Christelle Nguyen MD a b e, Hendy Abdoul MD f, Raphaël Campagna MD c *, Henri Guerini MD c *, Léa Jilet MSc f, Catherine Bedin OT b, Franck Chagny OT b, Gaëlle Couraud MD b, Camille Daste MD a b g, Prof Jean-Luc Drapé MD a c g, Rémy Fléchon OT b, Charlotte Gil MD b, Corinne Guérin PharmD d, Marie-Martine Lefèvre-Colau MD a b g h, Prof Serge Poiraudeau MD a b g h †, Estelle Randriamampandry OT b, Alexandra Roren PT b h, Prof Antoine Feydy MD a c g, Prof François Rannou MD a b e
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform
doi : 10.1016/S2665-9913(22)00098-4
Volume 4, Issue 7, July 2022, Pages e490-e506
Integrated analysis of dermal blister fluid proteomics and genome-wide skin gene expression in systemic sclerosis: an observational study
doi : 10.1016/S2665-9913(22)00094-7
Volume 4, Issue 7, July 2022, Pages e507-e516
Research priority setting for paediatric rheumatology in the UK
doi : 10.1016/S2665-9913(22)00106-0
Volume 4, Issue 7, July 2022, Pages e517-e524
